Category Archives: Regenerative Medicine

Cryoport to showcase cryogenic logistics solutions with cloud-based logistics management platform, the Cryoportal, at Booth #29

LAKE FOREST, Calif. Cryoport, Inc. (OTCBB: CYRX) ("the Company") today announced that it is exhibiting its cryogenic logistics solutions, equipped with its cloud-based logistics management platform, the Cryoportal, and its Cryoport Express Packaging Solutions at the 9(th) Annual World Stem Cells and Regenerative Medicine Congress 2014 in London on May 20-22, 2014, at Booth #29.

Cryoport's Chief Executive Officer, Jerrell Shelton; Chief Commercial Officer, Steven Leatherman; and Commercial Director of EMEA, Soren Knudsen, will be available for partnering and networking sessions during the conference.

"We are experiencing significant interest and demand for our innovative cryogenic logistics solutions within this exciting and fast growing segment of the life science arena," stated Mr. Leatherman. "Our cryogenic logistics solutions assure both our clients and their end-users that the integrity of the commodities shipped are appropriately maintained by providing unmatched transparency, thus offering peace of mind throughout the entire documented logistics process."

Mr. Shelton added, "As the application of stem cells to regenerative medicine grows, the very face of medicine changes. Stem cell applications are broad and reach into multiple medical practices. We understand the challenges life science companies face in the frozen shipping of biologics and virtually eliminate the risks through our reliable and innovative logistics solutions."

About The World Stem Cells and Regenerative Medicine Congress The World Stem Cells and Regenerative Medicine Congress 2014 is now in its 9th year and is Europe's largest and most senior conference and business development event for the stem cell and cell therapy industry. The World Stem Cells and Regenerative Medicine Congress brings together biopharma leaders, stakeholders, influencers and end users looking for translational research, business development and commercialisation. It is a proven conference and exhibition that delivers the innovators, disruptors and influencers from across the complete value chain. For more information on the event, please visit http://www.terrapinn.com/conference/stem-cells/?utm_source=cryoport&utm_medium=pressrelease&utm_campaign=cryoport

About Cryoport, Inc. Cryoport provides leading-edge cryogenic logistics solutions to the life sciences industry through the combination of purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. Its competencies range from skilled, total turnkey management of the entire life sciences cold chain logistics process to complex total management solutions for outsourced cold chain logistics.

Its packaging, built around its Cryoport Express liquid nitrogen dry vapor shippers, is validated to maintain a constant -150C temperature for a 10-plus day dynamic shipment duration. Its information technology boast its Cryoportal Logistics Management Platform which manages the entire logistics process, including initial order input, document preparation, customs document preparation and clearance, integrator/courier management, shipment tracking, issue resolution, intervention, when necessary, and delivery. Cryoport uses recyclable and reusable components providing an environmentally friendly solution. Cryoport solutions can record the "chain of condition" and "chain of custody" for shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes. For more information, visit http://www.cryoport.com.

Cryoport Contacts: Todd Fromer / Garth Russell tfromer@kcsa.com / grussell@kcsa.com P: 01-212-682-6300

Source Cryoport, Inc.

Link:
Cryoport Sponsors the 9th Annual World Stem Cells and Regenerative Medicine Congress 2014 in ...

There have been several revolutions in biotechnology that open the door to many new products and technologies. The first, recombinant DNA technology, allowed researchers for the first time to cut-and-splice DNA in any way they wished, thereby making it possible to assemble genes in new ways to manufacture a host of proteins like insulin, growth hormone, and erythropoietin.

The second revolution was called genomics and this technology allowed researchers to rapidly sequence and manipulate gene sequence information. Both recombinant DNA technology and genomics spawned the development and growth of many of todays leading biotechnology companies.

In our opinion, regenerative medicine has the potential to be a third major revolution in biotechnology. Empowered by the discovery of human embryonic stem (ES) cells, regenerative medicine now has the potential to produce any human cell type genetically modified in any way, to be used in the treatment of a host of degenerative diseases. Stem cells may also have commercial uses in the development of experimental new drugs. Under the leadership of Dr. Michael D. West, who pioneered this industry after he founded Geron Corporation and later during his tenure at Advanced Cell Technology, BioTime intends to become a significant biotechnology company in this emerging sector, focusing on near-term commercialization opportunities.

Read the original here:
Regenerative Medicine, The Third Major Revolution in ...

Regenerative Medicine in Equines
A multimedia project for the 2013 student bio expo (Danica Schmidtke, Emily Eastwood) How stem cells and PRP treatments have transformed the healing process ...

By: StudentBioExpo

See the original post here:
Regenerative Medicine in Equines - Video

Los Angeles, CA (PRWEB) April 19, 2014

MetroMD, Institute of Regenerative Medicine enunciates to offer laser skin resurfacing treatment to combat aging and deal with skin imperfections. Laser Skin treatment, alternatively known as DOT therapy is a new breakthrough in wellness industry. The revolutionary laser therapy is applied all over the face and neck to do away with frown lines, wrinkles, acne scars, unwanted folds, and sagging skin. The same laser is used to remove hyper pigmentation on the back of hands and tighten the loose, weathered skin along the forearms and thighs. The prominent institute in regenerative medicine industry runs a licensed Laser Skin Resurfacing Clinic Los Angeles. Source: Devin Stone, METROMD.

The breakthrough in the medical industry HGH, CO2 Fractional Laser, and Stem Cells are used together to combat the signs of aging, and overexposure to sunlight and to those who suffer from premature aging. Once administered the therapy increases blood flow, nearly vanishes the dark pigmented stains from UV rays," says Dr. Alex Martin, Medical Director at the Institute. The skins appearance becomes healthy and rejuvenated within three weeks of the procedure. The unique amalgamation of FDA approved CO2 Laser, Human Growth Hormone and Stem Cell therapies work wonder on skin to make it radiant and youthful even after the age of forty. Over the last decade, many breakthroughs have occurred at the beginning of 21st Century to deal with the multitude of skin woes without having the need to undergo any conventional surgical techniques and longer rehabilitation period.

About MetroMD MetroMD is a Los Angeles based clinical institute and a leading provider of PRP, Stem Cell Therapy, Botox, Laser Skin Resurfacing and other innovative treatments. The institute treats the patients with latest technology to treat aging, improve sports performance, texture of hair, nail, libido enhancement with HGH therapy. All the treatments are FDA approved and hence considered safe. The institute runs licensed Stem Cell Therapy clinic in Los Angeles. HGH treatment is clinically proven to treat Human Growth Deficiency with excellent results.

MetroMD Institute of Regenerative Medicine 7080 Hollywood Blvd, Suite 804 Los Angeles, CA 90028 (323) 285-5300

View original post here:
Los Angeles Based Clinic MetroMD Expands Its Treatments of DOT Therapy, One of the Best Laser Skin Treatments for ...

It may not be to quite the same level achieved by Victor Frankenstein, but work by a team from the University of Edinburgh is likely to have significant real-world implications in the field of regenerative medicine. For the first time, the team has successfully regenerated a living organ in mice, not by using a jolt of electricity, but by manipulating DNA.

The organ in question was the thymus, which is located next to the heart and is an integral part of the immune system. In humans, it achieves most of its growth in early life, continuing to then grow slowly until puberty when it slowly begins to shrink for the remainder of a person's life. It's deterioration with age leaves older people with greater susceptibility to infections, such as flu.

In a study led by researchers from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh, levels of a protein called FOXN1, which is produced by cells of the thymus and helps control how important genes are switched on and off, was increased. This instructed the stem cell-like cells to rebuild the organ in very old mice.

This resulted in the thymus being regenerated to have a similar structure to those found in a young mouse, with the organ's function restored and the mice producing more white blood cells called T cells, which play a central role in fighting infection.

The breakthrough could lead to new therapies for the treatment of people with damaged immune systems and genetic conditions that affect thymus development, such as DiGeorge syndrome. However, the team says more work will need to be done to ensure the process can be tightly controlled before the approach is tested on humans.

"One of the key goals in regenerative medicine is harnessing the bodys own repair mechanisms and manipulating these in a controlled way to treat disease," says Dr Rob Buckle, the Head of Regenerative Medicine at the MRC. "This interesting study suggests that organ regeneration in a mammal can be directed by manipulation of a single protein, which is likely to have broad implications for other areas of regenerative biology."

The team's study is published in the journal Development.

Source: University of Edinburgh

Read more:
World-first regeneration of a living organ

StemCells, Inc.

By: Alliance for Regenerative Medicine

See more here:
StemCells, Inc. - Video

Autism and Stem Cells: A Mom #39;s Perspective
Jen, a mother of 10 year-old Milo who has a severe form of autism describes the impact of the disorder on her family and shares her thoughts about stem cell ...

By: California Institute for Regenerative Medicine

Visit link:
Autism and Stem Cells: A Mom's Perspective - Video

Regenerative Medicine
Regenerative Medicine is a same-day, non-surgical adult stem cell procedure for treating common injuries and degenerative joint conditions. Hear how one pati...

By: ProMedica

Read more:
Regenerative Medicine - Video

March 20, 2014 - Orphan Disease Forum, Regenerative Medicine Forum, Personalized Medicineand Diagnostics Forum, and Vaccines& Immunotherapeutics Forum will highlight pressing health issues at 2014 BIO International Convention, which will take placeJune 2326 in in San Diego, CA. According to BIO International Convention President Scott Whitaker,these "highly-focused and interactive forums" will provide educational content and provide dedicated time for collaboration and networking with industry peers. Biotechnology Industry Organization 1201 Maryland Ave., SW, Ste. 900 Washington, DC, 20024 USA Press release date: March 13, 2014

New Forums to focus on orphan diseases, personalized medicine, regenerative medicine and vaccines

2014 BIO International Convention WASHINGTON--The Biotechnology Industry Organization (BIO) today announced Specialty Forums that will highlight the most pressing health issues facing our industry at the 2014 BIO International Convention in San Diego . The Convention, June 23-26, attracts the biggest names in biotech, offers key networking and partnering opportunities and provides insights and inspiration on major trends affecting the industry. New at BIO 2014, programming will take place for three full days from Tuesday, June 24th through Thursday, June 26th.

These new, highly-focused and interactive forums will not only provide great educational content, but will culminate in a unique and dedicated time for collaboration and networking with your industry peers. We are excited that these new session formats will offer an improved three-day Convention educational experience.

Today, the biotech industry is faced with more promise and greater challenges than we have seen in years. As a result of these challenges, the Convention has designed a series of new Specialty Forums which will offer in-depth conversations and unique perspectives from top business leaders and scientists working to develop the next generation of miracle medicines, said Scott Whitaker, President of the BIO International Convention. These new, highly-focused and interactive forums will not only provide great educational content, but will culminate in a unique and dedicated time for collaboration and networking with your industry peers. We are excited that these new session formats will offer an improved three-day Convention educational experience.

Sponsored by CSL Behring and Genzyme, a Sanofi company, the Orphan Disease Forum, June 24, will provide a unique perspective on the international orphan drug marketplace, new and emerging funding models, the vital role of patient advocacy organizations and the scientific and regulatory considerations for orphan drug development.

The Regenerative Medicine Forum, June 25, will delve into the ways stem cell science and regenerative medicine are impacting the biotechnology and pharmaceutical industries as well as the reasons why the reimbursement community has started to watch the developments in this rapidly emerging field. New for BIO 2014, the California Institute for Regenerative Medicine will sponsor this forum.

Spanning June 25-26, the Personalized Medicine & Diagnostics Forum and the Vaccines & Immunotherapeutics Forum will hear from business thought leaders from Ernst & Young, Roche and Foundation Medicine as well as key partners such as the Bill and Melinda Gates Foundation and the European Commission.

Advance media registration is now available for qualified reporters working full time for print, broadcast and web publications with valid press credentials. To register, please visit here.

For registration, schedule at a glance and exhibitor information, visit 2014 BIO International Convention. Once registered, search all attendees, sessions, events, exhibitors, partnering companies and more with myBIO.

Go here to see the original:
BIO Announces New Health Focused Specialty Forums at the 2014 BIO International Convention in ...

Sweden Medical Forum, part 14 - Dr. Petter Bjorquist, NovaHep
Dr. Petter Bjrquist, NovaHep AB "Development of biocompatible and individualized tissue engineered products using a novel stem cell technology" Find additio...

By: C0Orinir

Go here to read the rest:
Sweden Medical Forum, part 14 - Dr. Petter Bjorquist, NovaHep - Video